Aerovate Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Operating Revenue	236,620	232,415	195,474	172,374	151,099	144,035	Upgrade
Other Revenue	-543	-	-	-	-	-	Upgrade
Revenue	236,077	232,415	195,474	172,374	151,099	144,035	Upgrade
Revenue Growth (YoY)	14.52%	18.90%	13.40%	14.08%	4.90%	1.05%	Upgrade
Cost of Revenue	67,418	65,384	63,937	64,707	56,857	49,434	Upgrade
Gross Profit	168,659	167,031	131,537	107,667	94,242	94,601	Upgrade
Selling, General & Admin	52,756	51,539	42,454	37,648	32,472	31,237	Upgrade
Other Operating Expenses	47,915	46,726	36,047	34,263	29,873	29,299	Upgrade
Operating Expenses	110,063	107,429	86,145	79,139	69,501	67,245	Upgrade
Operating Income	58,596	59,602	45,392	28,528	24,741	27,356	Upgrade
Interest Expense	-1,460	-935	-440	-1,255	-1,144	-1,559	Upgrade
Interest & Investment Income	1,862	1,862	1,281	768	696	500	Upgrade
Earnings From Equity Investments	733	578	1,184	946	462	474	Upgrade
Currency Exchange Gain (Loss)	2,457	1,634	806	2,843	1,482	-92	Upgrade
Other Non Operating Income (Expenses)	948	31	-11	251	622	61	Upgrade
EBT Excluding Unusual Items	63,136	62,772	48,212	32,081	26,859	26,740	Upgrade
Merger & Restructuring Charges	-	-	-177	-101	-	-	Upgrade
Impairment of Goodwill	-1,350	-1,350	-	-5,941	-	-	Upgrade
Gain (Loss) on Sale of Investments	590	590	1,385	596	874	-187	Upgrade
Gain (Loss) on Sale of Assets	345	345	134	208	-17	-36	Upgrade
Asset Writedown	-846	-846	-	-	-	-731	Upgrade
Other Unusual Items	-666	-666	-281	-	1,127	-1,320	Upgrade
Pretax Income	61,209	60,845	49,273	26,843	28,843	24,466	Upgrade
Income Tax Expense	14,098	14,119	9,775	5,878	5,117	1,936	Upgrade
Earnings From Continuing Operations	47,111	46,726	39,498	20,965	23,726	22,530	Upgrade
Earnings From Discontinued Operations	-	-	230	-46	22,457	-680	Upgrade
Net Income to Company	47,111	46,726	39,728	20,919	46,183	21,850	Upgrade
Minority Interest in Earnings	-1,387	-1,471	-1,133	-1,316	-1,310	-514	Upgrade
Net Income	45,724	45,255	38,595	19,603	44,873	21,336	Upgrade
Net Income to Common	45,724	45,255	38,595	19,603	44,873	21,336	Upgrade
Net Income Growth	9.06%	17.26%	96.88%	-56.31%	110.32%	81.34%	Upgrade
Shares Outstanding (Basic)	1,006	1,006	1,012	1,016	1,024	1,024	Upgrade
Shares Outstanding (Diluted)	1,006	1,006	1,012	1,016	1,024	1,024	Upgrade
Shares Change (YoY)	-0.43%	-0.56%	-0.37%	-0.79%	-	-	Upgrade
EPS (Basic)	45.44	44.97	38.14	19.30	43.83	20.84	Upgrade
EPS (Diluted)	45.44	44.97	38.14	19.30	43.83	20.84	Upgrade
EPS Growth	9.53%	17.92%	97.61%	-55.97%	110.32%	81.34%	Upgrade
Free Cash Flow	-	50,641	22,897	16,579	9,019	24,399	Upgrade
Free Cash Flow Per Share	-	50.33	22.63	16.32	8.81	23.83	Upgrade
Dividend Per Share	-	11.000	3.000	6.000	2.500	3.500	Upgrade
Dividend Growth	-	266.67%	-50.00%	140.00%	-28.57%	-	Upgrade
Gross Margin	71.44%	71.87%	67.29%	62.46%	62.37%	65.68%	Upgrade
Operating Margin	24.82%	25.64%	23.22%	16.55%	16.37%	18.99%	Upgrade
Profit Margin	19.37%	19.47%	19.74%	11.37%	29.70%	14.81%	Upgrade
Free Cash Flow Margin	-	21.79%	11.71%	9.62%	5.97%	16.94%	Upgrade
EBITDA	67,677	68,303	52,572	35,344	31,695	34,152	Upgrade
EBITDA Margin	28.67%	29.39%	26.90%	20.50%	20.98%	23.71%	Upgrade
D&A For EBITDA	9,081	8,701	7,180	6,816	6,954	6,796	Upgrade
EBIT	58,596	59,602	45,392	28,528	24,741	27,356	Upgrade
EBIT Margin	24.82%	25.64%	23.22%	16.55%	16.37%	18.99%	Upgrade
Effective Tax Rate	23.03%	23.21%	19.84%	21.90%	17.74%	7.91%	Upgrade
Revenue as Reported	239,689	235,110	198,315	174,240	153,346	144,491	Upgrade
Advertising Expenses	-	3,368	2,957	2,573	2,514	2,543	Upgrade

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.